Last reviewed · How we verify
NCT05464550: RFASD
Role of Self-focused Attention in Depression
NA trial testing Eye tracker in Depression in 30 participants. Completed in 16 June 2022.
15 June 2022
Quick facts
| Lead sponsor | Centre Hospitalier Henri Laborit |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | other |
| Enrollment | 30 |
| Start date | 8 December 2021 |
| Primary completion | 15 June 2022 |
| Estimated completion | 16 June 2022 |
| Sites | 1 location across France |
Drugs / interventions tested
- Eye tracker
Conditions studied
- Depression — all drugs for Depression →
Sponsor
Centre Hospitalier Henri Laborit
Who can join
Adults 18 to 60, any sex, with Depression. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Using a task measuring the tracking of eye movements, the aim of this study is to demonstrate that individuals suffering from depression focus their attention more on their reflection in the screen after recalling a failure (and this all the more so as their depressive symptomatology is strong) .
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05464550
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Eye tracker
Trials testing the same drug.
- NCT04360291 — Impact of Visual Field Restriction on Visual Exploration · unknown
Other recruiting trials for Depression
Currently open trials in the same condition.
- NCT07336238 — Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or · Phase 2 · recruiting
- NCT06906939 — A Randomized Pilot rTMS Trial for Knee Arthritis Pain and Depression · EARLY_PHASE1 · recruiting
- NCT07517549 — Sexual Health Education During Pregnancy · NA · recruiting
- NCT06408246 — ACE-D Aim 3 Clinical Cognitive Trial to Enhance Translation in Depression · Phase 2 · recruiting
- NCT07449676 — Effects of an Innovative TCM-based Tui Jing Therapy on Psychological and Neurophysiological Functions in Depression · NA · recruiting
Other Centre Hospitalier Henri Laborit trials
Trials by the same sponsor.
- NCT07429500 — tDCS and Symptom Provocation in Treatment-Resistant OCD · NA · not yet recruiting
- NCT07015502 — Self-Dehumanization and Hesitation to Report Domestic Violence · recruiting
- NCT07274722 — Influence of Control Deprivation on the Use of the Analytical Cognitive Style in Anorexic Subjects · NA · recruiting
- NCT06093919 — Study of Prevalence of Eating Disorder in Liver Transplant Patients · completed
- NCT06009523 — Effects of Transcranial Direct Current Stimulation (tDCS) in the Management of Suicidal Ideation · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05464550 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Centre Hospitalier Henri Laborit
- Last refreshed: 24 May 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05464550.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing